$GPGI

GPGI (GPGI) Q2 2026 Earnings Call Transcript

GPGI, Inc. (GPGI) reported Q2 2026 results on an earnings call. Pro forma adjusted net sales were $473.2 million, down 4%, and pro forma adjusted EBITDA was $113.9 million, down 13%, with margin at 24.1%. GAAP net income was $50.3 million. FY2026 guidance: revenue $1.95B-$2.1B, adjusted EBITDA $550M-$610M, and free cash flow $275M-$325M.

Original reporting
Published Aug 13, 2026, 1:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 2:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
GPGI (GPGI) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$GPGINeutralMed
01

Why it matters

Management delivered Q2 results aligned with internal expectations, improved GAAP net income, and reiterated FY 2026 revenue, EBITDA, EBITDA margin, and free cash flow guidance while adjusting margin assumptions for tariff pass-through and mix.

02

Market read

Traders can update models using the specific FY 2026 guidance ranges and the stated drivers behind margin and cash flow, especially the ongoing Husky volume and FX sensitivity.

03

What to watch

Debt reduction and platform acquisition evaluation are mentioned, but the transcript emphasizes leverage targets and cash generation without detailing near-term capex or acquisition timing, which could affect how traders underwrite the FCF path.

Relevance 8/10Novelty 7/10Timing: today’s earnings call transcript, guidance ranges reiterated for FY 2026

Background

GPGI’s Q2 2026 call covers performance across CompoSecure and Husky under the Resolute Operating System framework, following the Resolute Holdings spin-off accounting structure.

Company-level read

Ticker impact

$GPGINeutralMedium confidence
Context

GPGI reported Q2 results and reiterated FY 2026 guidance, including revenue of $1.95B to $2.1B and pro forma EBITDA of $550M to $610M.

Expected impact

Moderate two-sided reaction risk, with upside if investors believe Husky margin sequential improvement can offset YoY declines.

Evidence & confidence

The article provides concrete Q2 metrics and full-year guidance ranges, but it frames key drivers (Husky volumes, FX, tariffs pass-through) as ongoing uncertainties rather than a clear inflection.

Market effects

Signals continued demand resilience at CompoSecure but highlights industrial capex deferrals at Husky tied to macro and geopolitics, relevant to metal security and industrial tooling demand expectations.

Geopolitical tension and FX impacts are cited as drivers of Husky margin pressure, implying sensitivity to regional risk and currency moves.

Tariff pass-through and system performance mix are explicitly incorporated into FY 2026 EBITDA margin guidance, pointing to global trade policy sensitivity.

Counterpoint

The sequential Husky margin improvement may not translate into YoY recovery if the company’s stated drivers (lower volumes, higher cost base, FX) persist longer than management expects.

Key entities

  • GPGI, Inc.

    Parent company reporting Q2 2026 results and FY 2026 guidance ranges across CompoSecure and Husky.

  • CompoSecure

    Reported record sales and margin expansion, with growth initiatives tied to the Resolute Operating System and Arculus momentum.

  • Husky

    Reported lower net sales and EBITDA YoY due to macro uncertainty, geopolitical tension, and higher cost base, despite sequential margin improvement.

  • Resolute Operating System (ROS)

    Management’s operational transformation program cited as driving efficiency, yield, and margin expansion.

Related articles

$GPGIMed

GPGI, Inc. (GPGI): Results of Operations and Financial Condition

GPGI, Inc. (GPGI) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 News Release GPGI Reports Second Quarter 2026 Results ▪ CompoSecure delivers record ROS-enabled results ▪ Husky performance in line with expectations ▪ ROS deployment accelerating at both companies ▪ Progress across the platform – reiterating full year 2026 guidance Second Quar

$GCOMed

102-year-old mall retailer quietly closes 25 stores

Genesco (GCO) closed 25 stores, including 17 Journeys locations, in Q2 fiscal 2027, per its earnings release. Net sales fell 3% YoY to $530M, with comparable sales down 1%. The company is shifting away from malls and remodeling stores to boost sales, with 4.0 Journeys stores showing 25% higher sales.

$EQIXMedAI 8/10

Equinix Is Doubling Down on AI Data Centers. How to Play EQIX Stock Here

Equinix (EQIX) reported Q2 revenue of $2.63B, up 16% YoY, beating estimates. AFFO was $11.78/share, up 19% YoY. The company raised full-year guidance and unveiled a multi-year growth plan. EQIX stock has surged 34% over the past year and offers a 1.98% dividend yield. Analysts rate it a 'Strong Buy' with an average price target of $1,232.19.

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.